| Jul 30 |
TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance
|
| Jul 12 |
Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves
|
| Jun 26 |
Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area
|
| Jun 21 |
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
|
| Jun 12 |
Hold TG Therapeutics For Intriguing Outcomes
|
| Jun 7 |
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
| Jun 3 |
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
|
| May 31 |
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
|
| May 30 |
Despite shrinking by US$192m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 131% over 5 years
|
| May 28 |
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
|
